Register by November 3 to get the lowest available rates for the San Antonio Breast Cancer Symposium (December 9-12), directed by Carlos L. Arteaga and Virginia G. Kaklamani. Learn more: https://t.co/alC96eZ4PH #SABCS25 @CarlosArteagaMD

.@OSUCCC_James researchers are using AI to better predict, diagnose lobular cancer https://t.co/twRBRxPfvu

New evidence prompts look at alcohol intake & effects on cancer risk: 1 drink/week can be too much 🍷 Alcohol tied to higher mortality for 7 cancer types, but reports show conflicting results Laura Tenner, MD, MPH, FASCO @unmc reviews the research: https://t.co/xsVEvMeJhV

Sarcomas comprise a heterogeneous group of malignant neoplasms that include genomically simple and genomically complex subtypes. This consensus provides guidelines for efficient, rational use of next-generation sequencing in their clinical management. https://t.co/iL5ZVB5UVD

Supporting local farmers, choosing healthy diets, wasting less, and helping to protect the soil and water are small acts that add up. Take part in these acts to celebrate the power food has to bring us together, nourish our communities and shape a better future. 🍴

Cancer survival is lower in rural areas, especially for Black patients. Expanding access to quality care for historically marginalized populations is critical to closing these gaps. Dr. @FarhadIslami & researchers at @AmericanCancer report: https://t.co/m8K26sXQld @OncoAlert

💊 Patients w/ advanced RCC whose disease progressed on first-line therapy may have a new option. FRUSICA-2 trial data showed that Fruzaqla + Tyvyt improved PFS & response rates vs standard therapies. @hutchmed #KidneyCancer Learn more! https://t.co/M8mtgzVo6A

Happening TODAY at 12 PM ET 📢 Join @NMQF for a live webinar: 🧠 Health Literacy in the Misinformation Age 📲 https://t.co/i7K16VN367 #HealthLiteracy #NMQF #PatientEducation

“#Encorafenib plus #cetuximab plus mFOLFOX6 is a practice-changing, new standard of care for people with metastatic #ColorectalCancer with a BRAFV600E mutation,” said Elena Elez, MD, PhD. Read more: https://t.co/dmtTx9EWTT

As we continue to navigate the current federal government shutdown, the MRF remains committed to ensuring the melanoma community feels informed and empowered when exploring all options following a diagnosis — including access to clinical trials. While some federally funded

In his Stephenson Global Prize lecture, AACR Past President Frank McCormick shared breakthroughs in RAS research, progress in pancreatic cancer, and his hope for preventing KRAS-driven cancers in the future. Learn more: https://t.co/aYkMir8v8D #AACRBlog @UCSFCancer @SGPCRI

In partnership with Research To Practice, join us for a special webinar for patients next Wednesday, Oct 22, about CAR T-cell therapy for non-lymphoma. @DrNeilLove #cartcelltherapy #nonHodgkinlymphoma Register here: https://t.co/kZ8Tlw1Rgp

Utilization of home health was significantly higher among Traditional Medicare vs Medicare Advantage beneficiaries, with 6.5% of TM beneficiaries receiving home health services in 2018 compared to 5.2% of MA beneficiaries overall. https://t.co/l4IMUAwzkb @wwamirhrc #ruralhealth

Triple Negative Breast Cancer (TNBC) is the most aggressive and hardest to treat—w/ higher risks of becoming metastatic. Black & Latina women are more often impacted. 🩷 Share your story: https://t.co/1XtlbzlwLB #SOSWithmBC #TNBC #BreastCancerAwareness

Proud to partner with @Medliveofficial on a #CME program sharing expert insights from 2025 #hematology & #lymphoma conferences. Learn how bispecific CAR T therapies may improve outcomes in relapsed/refractory LBCL & DLBCL. Watch on-demand for CME: https://t.co/JJN9bjFlqS

Got questions about GI cancer? Join the 16th Annual Ruesch Center Symposium Patient Day on Nov 22 and get answers from leading experts. @OncLive @LombardiCancer @MedStarGUH @RueschCenter Register: https://t.co/4CX3BCXf6Y

Check out our most recent Announcements & Resources email blast: https://t.co/1aL0x71cGu Want a quick and easy way to keep up with upcoming trainings, conferences, events, and resources? Visit our website at: https://t.co/EsagyBT6FK #kchwc #CommunityHealthWorkers

🩺 Dr. @MunverMD, of @JTCancerCenter, highlights benefits of minimally invasive kidney cancer surgery, multidisciplinary care, & long-term follow-up. Preserving kidney function while optimizing outcomes is possible. #KidneyCancer #CancerCare Read more: https://t.co/TvC9znFVI4

🚨 Join us Friday, November 7th for a day packed with the latest advancements in trauma medicine! 🚨 A virtual option is available! Don’t miss this opportunity to sharpen your skills and stay on the cutting edge of trauma care. Register today! https://t.co/yM2EMVDo3W

It's been two weeks and counting with neither Medicare telehealth waivers nor any guarantee of retroactive reimbursement. That's unsettling for both clinicians and patients nationwide, says the American Telemedicine Association. #telehealthpolicy